|
1
|
Kanis JA: Diagnosis of osteoporosis and
assessment of fracture risk. Lancet. 359:1929–1936. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clark P, Carlos F, Luis J and Martínez V:
Epidemiology, costs and burden of osteoporosis in Mexico. Arch
Osteoporos. 5:9–17. 2010. View Article : Google Scholar
|
|
3
|
Kylmäoja E, Nakamura M and Tuukkanen J:
Osteoclasts and remodeling based bone formation. Curr Stem Cell Res
Ther. 11:626–633. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamashita T, Takahashi N and Udagawa N:
New roles of osteoblasts involved in osteoclast differentiation.
World J Orthop. 3:175–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hemingway F, Cheng X, Knowles HJ, Estrada
FM, Gordon S and Athanasou NA: In vitro generation of mature human
osteoclasts. Calcif Tissue Int. 89:389–395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Y, Deng HW and Shen H: Circulating
monocytes: An appropriate model for bone-related study. Osteoporos
Int. 26:2561–2572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kwan Tat S, Padrines M, Théoleyre S,
Heymann D and Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: Interrelations
in bone resorption pathophysiology. Cytokine Growth Factor Rev.
15:49–60. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Deng FY, Lei SF, Zhang Y, Zhang YL, Zheng
YP, Zhang LS, Pan R, Wang L, Tian Q, Shen H, et al: Peripheral
blood monocyte-expressed ANXA2 gene is involved in pathogenesis of
osteoporosis in humans. Mol Cell Proteomics. 10:M111.0117002011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deng FY, Liu YZ, Li LM, Jiang C, Wu S,
Chen Y, Jiang H, Yang F, Xiong JX, Xiao P, et al: Proteomic
analysis of circulating monocytes in Chinese premenopausal females
with extremely discordant bone mineral density. Proteomics.
8:4259–4272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng Y, Zhang L, Zhu W, Xu C, He H, Zhou
Y, Liu YZ, Tian Q, Zhang JG, Deng FY, et al: Quantitative
proteomics and integrative network analysis identified novel genes
and pathways related to osteoporosis. J Proteomics. 142:45–52.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carthew RW and Sontheimer EJ: Origins and
Mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lian F, Cui Y, Zhou C, Gao K and Wu L:
Identification of a plasma four-microRNA panel as potential
noninvasive biomarker for osteosarcoma. PLoS One. 10:e01214992015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao N, Han D, Liu Y, Li Y, Zeng L, Wang Y
and Feng H: DLX3 negatively regulates osteoclastic differentiation
through microRNA-124. Exp Cell Res. 341:166–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA. 105:pp.
10513–10518. 2008, View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hackl M, Heilmeier U, Weilner S and
Grillari J: Circulating microRNAs as novel biomarkers for bone
diseases - Complex signatures for multifactorial diseases? Mol Cell
Endocrinol. 432:83–95. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meng J, Zhang D, Pan N, Sun N, Wang Q, Fan
J, Zhou P, Zhu W and Jiang L: Identification of miR-194-5p as a
potential biomarker for postmenopausal osteoporosis. PeerJ.
3:e9712015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ji X, Chen X and Yu X: MicroRNAs in
osteoclastogenesis and function: Potential therapeutic targets for
osteoporosis: Int J Mol Sci. 17:3492016.
|
|
18
|
Denova-Gutiérrez E, Flores YN,
Gallegos-Carrillo K, Ramírez-Palacios P, Rivera-Paredez B,
Muñoz-Aguirre P, Velázquez-Cruz R, Torres-Ibarra L, Meneses-León J,
Méndez-Hernández P, et al: Health workers cohort study: methods and
study design. Salud Publica Mex. 58:708–716. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Velázquez-Cruz R, García-Ortiz H,
Castillejos-López M, Quiterio M, Valdés-Flores M, Orozco L,
Villarreal-Molina T and Salmerón J: WNT3A gene polymorphisms are
associated with bone mineral density variation in postmenopausal
Mestizo women of an urban Mexican population: Findings of a
pathway-based high-density single nucleotide screening. Age
(Dordr). 36:96352014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Denova-Gutiérrez E, Castañón S, Talavera
JO, Flores M, Macías N, Rodríguez-Ramírez S, Flores YN and Salmerón
J: Dietary patterns are associated with different indexes of
adiposity and obesity in an urban Mexican population. J Nutr.
141:921–927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bolstad BM: Low level analysis of
high-density oligonucleotide array data: Background, normalization
and sumarizationPhD dissertation. University of California;
Berkeley: 2004
|
|
23
|
Carvalho BS and Irizarry RA: A framework
for oligonucleotide microarray preprocessing. Bioinformatics.
26:2363–2367. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wettenhall JM and Smyth GK: limmaGUI: A
graphical user interface for linear modeling of microarray data.
Bioinformatics. 20:3705–3706. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X: miRDB: A microRNA target
prediction and functional annotation database with a wiki
interface. RNA. 14:1012–1017. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X and El Naqa IM: Prediction of both
conserved and nonconserved microRNA targets in animals.
Bioinformatics. 24:325–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
30
|
Siepel A, Bejerano G, Pedersen JS,
Hinrichs AS, Hou M, Rosenbloom K, Clawson H, Spieth J, Hillier LW,
Richards S, et al: Evolutionarily conserved elements in vertebrate,
insect, worm and yeast genomes. Genome Res. 15:1034–1050. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Stat Soc. 57:289–300. 1995.
|
|
32
|
Feng X: RANKing intracellular signaling in
osteoclasts. IUBMB Life. 57:389–395. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Johnson ME, Deliard S, Zhu F, Xia Q, Wells
AD, Hankenson KD and Grant SFA: A ChIP-seq-defined genome-wide map
of MEF2C binding reveals inflammatory pathways associated with its
role in bone density determination. Calcif Tissue Int. 94:396–402.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feng HT, Cheng T, Steer JH, Joyce DA,
Pavlos NJ, Leong C, Kular J, Liu J, Feng X, Zheng MH and Xu J:
Myocyte enhancer factor 2 and microphthalmia-associated
transcription factor cooperate with NFATc1 to transactivate the
V-ATPase d2 promoter during RANKL-induced osteoclastogenesis. J
Biol Chem. 284:14667–14675. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Westra WH, Sturm P, Drillenburg P, Choti
MA, Klimstra DS, Albores-Saavedra J, Montag A, Offerhaus GJ and
Hruban RH: K-ras oncogene mutations in osteoclast-like giant cell
tumors of the pancreas and liver: Genetic evidence to support
origin from the duct epithelium. Am J Surg Pathol. 22:1247–1254.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bozec A, Bakiri L, Hoebertz A, Eferl R,
Schilling AF, Komnenovic V, Scheuch H, Priemel M, Stewart CL,
Amling M and Wagner EF: Osteoclast size is controlled by Fra-2
through LIF/LIF-receptor signalling and hypoxia. Nature.
454:221–225. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chaisson ML, Branstetter DG, Derry JM,
Armstrong AP, Tometsko ME, Takeda K, Akira S and Dougall WC:
Osteoclast differentiation is impaired in the absence of inhibitor
of kappa B kinase alpha. J Biol Chem. 279:54841–54848. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Song H, Kim H, Lee K, Lee DH, Kim TS, Song
JY, Lee D, Choi D, Ko CY, Kim HS, et al: Ablation of Rassf2 induces
bone defects and subsequent haematopoietic anomalies in mice. EMBO
J. 31:1147–1159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang X and Li B: Genetic studies of bone
diseases: Evidence for involvement of DNA damage response proteins
in bone remodeling. Int J Biomed Sci. 3:217–228. 2007.PubMed/NCBI
|
|
40
|
Zhao B, Takami M, Yamada A, Wang X, Koga
T, Hu X, Tamura T, Ozato K, Choi Y, Ivashkiv LB, et al: Interferon
regulatory factor-8 regulates bone metabolism by suppressing
osteoclastogenesis. Nat Med. 15:1066–1071. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu YZ, Dvornyk V, Lu Y, Shen H, Lappe JM,
Recker RR and Deng HW: A novel pathophysiological mechanism for
osteoporosis suggested by an in vivo gene expression study of
circulating monocytes. J Biol Chem. 280:29011–29016. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xiao P, Chen Y, Jiang H, Liu YZ, Pan F,
Yang TL, Tang ZH, Larsen JA, Lappe JM, Recker RR and Deng HW: In
vivo genome-wide expression study on human circulating B cells
suggests a novel ESR1 and MAPK3 network for postmenopausal
osteoporosis. J Bone Miner Res. 23:644–654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
de la Rica L, García-Gómez A, Comet NR,
Rodríguez-Ubreva J, Ciudad L, Vento-Tormo R, Company C,
Álvarez-Errico D, García M, Gómez-Vaquero C and Ballestar E:
NF-κB-direct activation of microRNAs with repressive effects on
monocyte-specific genes is critical for osteoclast differentiation.
Genome Biol. 16:22015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Saito E, Suzuki D, Kurotaki D, Mochizuki
A, Manome Y, Suzawa T, Toyoshima Y, Ichikawa T, Funatsu T, Inoue T,
et al: Down-regulation of Irf8 by Lyz2-cre/loxP accelerates
osteoclast differentiation in vitro. Cytotechnology. 69:443–450.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yáñez A and Goodridge HS: Interferon
regulatory factor 8 and the regulation of neutrophil, monocyte, and
dendritic cell production. Curr Opin Hematol. 23:11–17. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Boyce BF, Xiu Y, Li J, Xing L and Yao Z:
NF-κB-mediated regulation of osteoclastogenesis. Endocrinol Metab
(Seoul). 30:35–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kimura T, Jiang S, Yoshida N, Sakamoto R
and Nishizawa M: Interferon-alpha competing endogenous RNA network
antagonizes microRNA-1270. Cell Mol Life Sci. 72:2749–2761. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Coelho LF, de Freitas Almeida Magno G,
Mennechet FJ, Blangy A and Uzé G: Interferon-alpha and -beta
differentially regulate osteoclastogenesis: Role of differential
induction of chemokine CXCL11 expression. Proc Natl Acad Sci USA.
102:pp. 11917–11922. 2005, View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yim HY, Park C, Lee YD, Arimoto K, Jeon R,
Baek SH, Zhang DE, Kim HH and Kim KI: Elevated response to type I
IFN enhances RANKL-mediated osteoclastogenesis in usp18-knockout
mice. J Immunol. 196:3887–3895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Johnell O, Kanis JA, Oden A, Johansson H,
De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D,
et al: Predictive value of BMD for hip and other fractures. J Bone
Miner Res. 20:1185–1194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cao Z, Moore BT, Wang Y, Peng XH, Lappe
JM, Recker RR and Xiao P: MiR-422a as a potential cellular microRNA
biomarker for postmenopausal osteoporosis. PLoS One. 9:e970982014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen C, Cheng P, Xie H, Zhou HD, Wu XP,
Liao EY and Luo XH: MiR-503 regulates osteoclastogenesis via
targeting RANK. J Bone Miner Res. 29:338–347. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang Y, Li L, Moore BT, Peng XH, Fang X,
Lappe JM, Recker RR and Xiao P: MiR-133a in human circulating
monocytes: A potential biomarker associated with postmenopausal
osteoporosis. PLoS One. 7:e346412012. View Article : Google Scholar : PubMed/NCBI
|
